within Pharmacolibrary.Drugs.D_Dermatologicals.D01A_AntifungalsForTopicalUse.D01AE16_Amorolfine;

model Amorolfine
  extends Pharmacolibrary.Drugs.ATC.D.D01AE16;

  annotation (Documentation(
info       = "<html><body><table><tr><td>Drug:</td><td>D01AE16</td></tr><td>route:</td><td>topical</td></tr><tr><td>n-compartments</td><td>1</td></tr></table><p>Amorolfine is a topical antifungal agent, chemically a morpholine derivative, used primarily in the treatment of onychomycosis (fungal infections of the nails) and dermatophytosis. It inhibits ergosterol synthesis resulting in disruption of fungal cell membranes. Amorolfine is approved as a topical treatment in many countries but is not available in the United States.</p><h4>Pharmacokinetics</h4><p>Estimated parameters for healthy adults using topical application (nail lacquer), as no published pharmacokinetic models with detailed parameters available in literature.</p><h4>References</h4><ol><li><p>Gupta, AK, &amp; Talukder, M (2022). Efinaconazole in Onychomycosis. <i>American journal of clinical dermatology</i> 23(2) 207–218. DOI:<a href=\"https://doi.org/10.1007/s40257-021-00660-1\">10.1007/s40257-021-00660-1</a>  PUBMED:<a href=\"https://pubmed.ncbi.nlm.nih.gov/34902110/\">https://pubmed.ncbi.nlm.nih.gov/34902110</a></p></li><li><p>Gupta, AK, et al., &amp; Foley, KA (2014). Topical therapy for toenail onychomycosis: an evidence-based review. <i>American journal of clinical dermatology</i> 15(6) 489–502. DOI:<a href=\"https://doi.org/10.1007/s40257-014-0096-2\">10.1007/s40257-014-0096-2</a>  PUBMED:<a href=\"https://pubmed.ncbi.nlm.nih.gov/25257931/\">https://pubmed.ncbi.nlm.nih.gov/25257931</a></p></li><li><p>Haria, M, &amp; Bryson, HM (1995). Amorolfine. A review of its pharmacological properties and therapeutic potential in the treatment of onychomycosis and other superficial fungal infections. <i>Drugs</i> 49(1) 103–120. DOI:<a href=\"https://doi.org/10.2165/00003495-199549010-00008\">10.2165/00003495-199549010-00008</a>  PUBMED:<a href=\"https://pubmed.ncbi.nlm.nih.gov/7705210/\">https://pubmed.ncbi.nlm.nih.gov/7705210</a></p></li></ol></body></html>",
    revisions  = "<html><body><ul><li>06/2025 initial model generated by LLM gpt-4.1 from general data</li></ul></body></html>",
    experiment (StartTime = 0, StopTime = 86400, Tolerance = 1e-9, Interval = 1)
  ));
end Amorolfine;
